IP Library Granted Patent US 8,802,167
Granted Patent B2
US 8,802,167 · App. 13/115,395 · Granted Aug 12, 2014

Use of

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,802,167
App. No.
13/115,395
Granted
Aug 12, 2014
Kind
B2
Abstract

The present invention describes compositions and methods for improving the appearance of skin, particularly, treating, ameliorating, preventing, delaying, and/or improving one or more signs of excess accumulation and/or production of subcutaneous fat, such as cellulite, and conditions related thereto, by topically applying compositions comprising Eclipta prostrata extracts or other anti-lipid agents.

Claims (22)

1. A method for improving the appearance of skin affected by cellulite comprising topically applying thereto an effective amount of an extract of Eclipta prostrata in a cosmetically acceptable vehicle for a time sufficient to improve the appearance of said skin.

2. The method according to claim 1 , wherein said Eclipta prostrata extract is in combination with at least one other anti-lipid agent.

3. The method according to claim 2 , wherein said at least one other anti-lipid agent comprises at least one agent selected from the group consisting of a phophodiesterase inhibitor, an adenylate cyclase activator, a lipolysis stimulator, a beta-adrenergic receptor agonist, and an alpha-2-adreneric receptor antagonist.

4. The method according to claim 2 , wherein said at least one other anti-lipid agent comprises at least one agent selected from the group consisting of a xanthine analog, forskolin, a forskohlii extract, a hawthorne extract, a cola extract, isoproterenol, yohimbine, Ginkgo biloba extract, and perilla oil.

5. The method according to claim 2 , wherein said at least one other anti-lipid agent is caffeine.

6. The method according to claim 1 , wherein said Eclipta prostrata extract is in combination with at least one collagen and/or elastin stimulator.

7. The method according to claim 1 , wherein said Eclipta prostrata extract is in combination with carnitine, creatine, and/or a carnitine creatinate salt.

8. The method according to claim 1 , wherein said cellulite is found on a thigh, buttocks, abdomen, hip, and/or upper arm region.

9. The method according to claim 1 , wherein said composition is a leave-on composition.

10. The method according to claim 1 , wherein said topical application comprises daily application for a period of at least 4 weeks.

11. A method for improving the appearance of skin affected by cellulite comprising topically applying thereto a composition comprising a peroxisome proliferator-activated receptor-gamma (PPARγ) inhibitor in a cosmetically acceptable vehicle in an amount effective to decrease adipocyte differentiation and/or intracellular triglyceride production and/or accumulation in adipocytes in said area of skin, for a time sufficient to improve the appearance of said skin; wherein said PPARγinhibitor is an Eclipta prostrate extract, and

wherein said PPARγinhibitor further inhibits stearoyl-CoA desaturasel (SCD1) and/or further stimulates tenascin-X production.

12. The method according to claim 11 , wherein said PPARγinhibitor is in combination with at least one other anti-lipid agent.

13. The method according to claim 12 , wherein said at least one other anti-lipid agent comprises at least one agent selected from the group consisting of a phophodiesterase inhibitor, an adenylate cyclase activator, a lipolysis stimulator, a beta-adrenergic receptor agonist, and an alpha-2-adreneric receptor antagonist.

14. The method according to claim 12 , wherein said at least one other anti-lipid agent comprises at least one agent selected from the group consisting of a xanthine analog, forskolin, a forskohlii extract, a hawthorne extract, a cola extract, isoproterenol, yohimbine, Ginkgo biloba extract, and perilla oil.

15. The method according to claim 12 , wherein said at least one other anti-lipid agent is caffeine.

16. The method according to claim 11 , wherein said cellulite is found on a thigh, buttocks, abdomen, hip, and/or upper arm region.

17. The method according to claim 11 , wherein said composition is a leave-on composition.

18. The method according to claim 11 , wherein said topical application comprises daily application for a period of at least 4 weeks.

19. A method for reducing the re-occurrence of cellulite in an area previously affected by cellulite comprising topically applying thereto an effective amount an extract of Eclipta prostrata in a cosmetically acceptable vehicle.

20. A method for reducing obesity comprising topically applying to an area affected by unwanted fat deposition and/or accumulation an effective amount an extract of Eclipta prostrata in a cosmetically acceptable vehicle, for a time sufficient to reduce said unwanted fat.

21. A method according to claim 1 , further comprising allowing said extract to mix with a gel before and/or upon said topical application, wherein said gel comprises an agent for imparting a cooling sensation to the skin.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Jan 28, 2026
From: NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA &CO UK HOLDINGS LIMITED, AS A SECURED PARTY
To: AVON PRODUCTS, INC.
Reel/Frame 074508/0281 →
RELEASE OF SECURITY INTEREST Recorded Dec 11, 2024
From: NATURA &CO HOLDING S.A.; NATURA COSMETICOS S.A.; NATURA &CO LUXEMBOURG HOLDINGS S.A R.L. - LUXEMBOURG; NATURA &CO UK HOLDINGS LIMITED - UK
To: AVON PRODUCTS, INC
Reel/Frame 069591/0494 →
PATENT SECURITY AGREEMENT Recorded Aug 16, 2024
From: AVON PRODUCTS, INC.
To: NATURA &CO HOLDING S.A.; NATURA &CO LUXEMBOURG HOLDINGS S.À R.L.; NATURA COSMÉTICOS S.A.; NATURA &CO UK HOLDINGS LIMITED
Reel/Frame 068659/0915 →
SECURITY INTEREST Recorded Apr 29, 2024
From: AVON PRODUCTS, INC.; MI HOLDINGS, INC.; AVON INTERNATIONAL OPERATIONS, INC.; AVON CAPITAL CORPORATION; AVON COSMETICS LIMITED; AVON BEAUTY LIMITED
To: NATURA &CO HOLDING S.A., AS SECURED PARTY; NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA COSMÉTICOS S.A., AS A SECURED PARTY
Reel/Frame 067249/0491 →
SECURITY INTEREST Recorded Aug 11, 2023
From: AVON PRODUCTS, INC.
To: NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA &CO UK HOLDINGS LIMITED, AS A SECURED PARTY
Reel/Frame 064566/0872 →
SECURITY INTEREST Recorded Nov 14, 2019
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A., LONDON BRANCH
Reel/Frame 051032/0210 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Aug 15, 2016
From: CITIBANK, N.A.
To: AVON PRODUCTS, INC.
Reel/Frame 039690/0331 →
SECURITY INTEREST Recorded Jun 12, 2015
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A.
Reel/Frame 035899/0776 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2011
From: HWANG, CHENG S.; SANTHANAM, UMA; RANDHAWA, MANPREET
To: AVON PRODUCTS, INC.
Reel/Frame 026338/0334 →